Get startedLog in
    Picture of Dogwood Therapeutics logo

    DWTX — Dogwood Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    All News

    Brief: Virios Therapeutics - Has Withdrawn Application For IND Focused On Treatment Of Irritable Bowel Syndrome By Its Lead Compound, IMC-1

    Picture of Dogwood Therapeutics logoDogwood Therapeutics
    17/12/2021 14:44
    Dec 17 (Reuters) - Virios Therapeutics Inc  VIRI.O :
    * VIRIOS THERAPEUTICS - HAS WITHDRAWN APPLICATION FOR IND
FOCUSED
ON TREATMENT OF IRRITABLE BOWEL SYNDROME BY ITS LEAD COMPOUND,
IMC-1
    * VIRIOS THERAPEUTICS - WILL REPORT PLANS FOR PRIORITIZING &
EXECUTING IBS, FATIGUE, & OTHER VIRAL MEDIATED RESEARCH RELATED
OPPORTUNITIES IN Q1 2022


Further company coverage:  VIRI.O 

 ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Dogwood Therapeutics

    See all news